Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Infiltration in Laparoscopic Cholecystectomy
NCT03543202Completed
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in biliary disease (3 arms), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Primary endpoint: Postoperative analgesia (Numeric Pain Scale) at 24 hours. Started Jun 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
biliary disease
Beyond the preview
Go deeper on NCT03543202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03543202.